Cerebrovascular diseases manifest as abnormalities of and disruption to the intracranial
vasculature and its capacity to carry blood to the brain. However, the pathogenesis of many …

2592 Stroke September 2019 it was observed that ASA usage alone for> 3 years was
associated with decreased odds of SAH (OR, 0.63; 95% CI, 0.45–0.90). No statistically …

OBJECTIVE The annual rupture rate of small (3–4 mm) unruptured cerebral aneurysms
(UCAs) is 0.36% per year, however, the proportion of small ruptured aneurysms< 5 mm is …

Background Aneurysmal subarachnoid hemorrhage (SAH) as a serious type of stroke is
frequently accompanied by a so-called initial thunderclap headache. However, the …

OBJECTIVE Adoption of endovascular treatment (EVT) and other advances in aneurysm
care have shifted practice patterns of cerebral aneurysm treatment over the past 2 decades …

Background: Mounting experimental evidence supports the concept that the RAAS (renin-
angiotensin-aldosterone system) is involved in the pathogenesis of intracranial aneurysm …

OBJECTIVE Aspirin has emerged as a potential agent in the prevention of rupture of
intracranial aneurysms (IAs). In this study, the authors' goal was to test if aspirin is protective …

Background and purpose The ever-growing availability of imaging led to increasing
incidentally discovered unruptured intracranial aneurysms (UIAs). We leveraged machine …

There is increasing interest in drug therapy for preventing aneurysmal subarachnoid
hemorrhage (aSAH). We aimed to comprehensively evaluate the association between drug …

OBJECTIVE The reason for a rebleed after an initial hemorrhage in patients with aneurysmal
subarachnoid hemorrhage (aSAH) is considered multifactorial. Antiplatelet use is one of the …